Drug Profile


Alternative Names: BP-1-5375; BP-1.5375; Immethridine dioxalate

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bioprojet
  • Class Antiallergics; Antiemetics; Antihistamines; Drug withdrawal therapies; Imidazoles; Pyridines; Small molecules
  • Mechanism of Action Histamine H3 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Unspecified

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Undefined in France (PO, Suspension)
  • 11 Oct 2013 Bioprojet plans a phase I/IIa trial in Healthy volunteers in the Netherlands (NCT01965301)
  • 31 May 2009 Preclinical trials in Undefined indication in France (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top